Company intelligence / Profile preview

Promus Equity Partners

Chicago, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Promus Equity Partners is not a drug developer, platform biotech, CRO, or CMO. It is an investment firm that has invested in some healthcare businesses—including Quest Products LLC, a consumer health company[6], and Biologos (a healthcare services company, not a drug developer)[13]—but does not itself own any biopharma pipeline, modalities, targets, or platform technologies. Its expertise is in capital management and strategic partnerships for company growth, supporting lower-middle-market management teams[1][3][9][12].

Industry: Investors

Beyond the preview

Go deeper on Promus Equity Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promus Equity Partners.

Explore the full profile